Skip to main content
SpringerLink
Log in

Zur Biologie der Mammakarzinome

  • Conference paper
Therapie des Mammakarzinoms

  • 9 Accesses

Zusammenfassung

In den vergangenen Jahren wurden eine Reihe von Lehrsätzen zur Biologie des Mammakarzinoms und damit auch einige Grundsätze ärztlichen Handelns in Vorsorge, Diagnostik und Therapie neu formuliert. In Tab. 1 werden solche älteren und neueren Auffassungen einander gegenüber gestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aldinger, K.: TSH and prolactin levels in breast cancer. Archs intern. Med. 138: 1638–1641 (1978)

    CAS  Google Scholar 

  2. Attiyeh, F. F., Jensen, M., Huvos, A. G. and Fracchia, A.: Axillary micrometastasis and macrometastasis in carcinoma of the breast. Surgery Gynec. Obstet. 144: 839–842 (1977)

    CAS  Google Scholar 

  3. Dowsett, M., McGarrick, G. E., Harris, A. L., Coombes, R. C., Smith, I. E. and Jeffcoate, S. L.: Prognostic significance of serum prolactin levels in advanced breast cancer. Br. J. Cancer. 47: 763–769 (1983)

    Article  PubMed  CAS  Google Scholar 

  4. Fisher B., Redmond, C., Fisher, E. R. and Participating NSABP Investigators: The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology — An overview of findings. Cancer. 46: 1009–1025 (1980)

    Article  PubMed  CAS  Google Scholar 

  5. Fisher, E. R., Palekar, A., Rockett, H., Redmond, C. and Fisher, B.: Pathologic findings from the National Surgical Adjuvant Breast Cancer Project (Protocol No. 4) V. Significance of axillary nodal micro-and macrometastases. Cancer. 42: 2032–2038 (1078)

    Article  Google Scholar 

  6. Haybittle, J. L., Blarney, R. W., Elston, C. W., Johnson, J., Doyle, P. J., Campbell, F. C., Nicholson, R. I. and Griffiths, K. A.: Prognostic index in primary breast cancer. Br. J. Cancer. 45: 361–366 (1982)

    Article  PubMed  CAS  Google Scholar 

  7. Holtkamp, W., von Heyden, D., Rauschecker, H. and Nagel, G. A.: Plasma-Prolactin-Konzentrationen bei Mammakarzinomen in verschiedenen Stadien bei Mastopathie und anderen malignen Tumoren. Schw. med. Wschr. 113: 1513–1520 (1983)

    CAS  Google Scholar 

  8. Howell, A., Harland, R. N. I., Bramwell, V. H. C., Swindell, R., Barnes, D. M., Redford, J., Wilkinson, M. J. S., Crowther, D. and Sellwood, R. A.: Steroid-Hormone Receptors and Survival after first relapse in breast cancer. The Lancet, March. 17, 588–591 (1983)

    Google Scholar 

  9. Huvos, A. G., Hutter, R. V. P. and Berg, J. W.: Significanc of axillary micrometastases and macrometastases in mammary cancer. Ann. Surg. 173: 44–46 (1971)

    Article  PubMed  CAS  Google Scholar 

  10. Millis, R. R.: Histopathologische prognostische Faktoren beim Mammakarzinom. In: Kubli, Nagel, Kadach, Kaufmann, Neue Wege in der Brustkrebsbehandlung, Akt. Onkologie 8, 79–90 ( Zuckschwerdt-Verlag, München, Bern, Wien 1983 )

    Google Scholar 

  11. Morgan, L. and Hobbs, J. R.: Prolactin receptors in human breast tumors. Proc. Soc. Endocrin: J. Endocrin. 73: 170 (1977)

    Google Scholar 

  12. Nagel, G. A. Holtkamp, W. and Wander, H. E.: Biologische und klinische Prognosefaktoren metastasierender Mammakarzinome. In: Kubli, Nagel Kadach, Kaufmann, Neue Wege in der Brustkrebsbehandlung, Akt. Onkologie 8, 91–105 ( Zuckschwerdt-Verlag München, Bern, Wien 1983 )

    Google Scholar 

  13. Nagel, G. A., Wander, H. E. und Blossey, Ch.: Hyperprolaktinämie beim metastasierenden Mammakarzinom. Schweiz. med. Wschr. 111: 1977–1979 (1981)

    CAS  Google Scholar 

  14. Wander, H. E. und Nagel, G. A. (Hrsg.): In: Mammakarzinome — Vorsorge, Therapie, Nachsorge, Besondere Fragestellungen. ( Zuckschwerdt-Verlag, München, Bern, Wien 1984 )

    Google Scholar 

  15. Willis, K. J., London, D. R., Ward, H. W. C., Butt, W. R., Lynch, S. S. and Rudd, B. R.: Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course. Br. med. J. 1: 425–428 (1977)

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. A. Nagel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. E. Wander
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Holtkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik, Poliklinik der Universität, Albert-Schweitzer-Str. 33, 4400, Münster, Deutschland

    Th. Büchner , D. Urbanitz  & J. van de Loo ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer: Berlin Heidelberg

About this paper

Cite this paper

Nagel, G.A., Wander, H.E., Holtkamp, W. (1985). Zur Biologie der Mammakarzinome. In: Büchner, T., Urbanitz, D., van de Loo, J. (eds) Therapie des Mammakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70033-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70033-0_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13778-8

  • Online ISBN: 978-3-642-70033-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation